Body mass index and serum markers associated with progression-free survival in lung cancer patients treated with immune checkpoint inhibitors

Table 3 Cox-multivariate analysis of the relationship between PFS and clinical factors in patients in this study

Parameter	Odds ratio	p-value	95%CI
Parameter	Odds ratio	p-value	Lower	Upper
Age	1.009	0.496	0.984	1.035
Sex	0.598	0.094	0.327	1.091
Treatment line	1.184	0.559	0.671	2.088
Histology	1.154	0.808	0.364	3.654
ICIs type	1.08	0.899	0.329	3.55
Serum ALB	0.438	0.024	0.214	0.899
Creatinine	0.509	0.021	0.287	0.902
BMI	0.703	0.219	0.401	1.233

ISSN: 1471-2407